denufosol tetrasodium (INS37217) Intravitreal Injection

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Cystoid Macular EdemaMacular Edema, CystoidRetinal DetachmentUveitis

Phase 1

A Study in Subjects With Retinal Detachment

CompletedNCT00210067

Merck Sharp & Dohme LLCRetinal Detachment

Start: 2001-05-31End: 2002-06-30Updated: 2015-10-09

Phase 2

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

TerminatedNCT00083967

Merck Sharp & Dohme LLCRetinal Detachment

Start: 2004-06-30End: 2006-04-30Updated: 2015-04-10

Study to Treat Uveitis Associated Macular Edema

TerminatedNCT00114062

Merck Sharp & Dohme LLCCystoid Macular Edema, Uveitis

Start: 2005-09-30End: 2006-12-31Updated: 2016-11-29

A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema

WithdrawnNCT00135655

Merck Sharp & Dohme LLCMacular Edema, Cystoid

Start: 2005-08-31Updated: 2013-05-21